Placeb

DRUG4 trials

Sponsors

Vice chancellor for research, Shiraz University of Medical Sciences, Qianfoshan Hospital, Grand Theravac Life Sciences (Nanjing) Co., Ltd., University of Oxford

Conditions

Chronic hepatitisBCoronary Artery DiseasePostoperative ShiveringPsychosisTreatment Resistant Psychosisschizophrenia. Schizophrenia

Phase 2

Zonisamide for prevention of Atypical (Second generation) antipsychotics associated weight gain in schizophrenia

Active, not recruitingIRCT201103283930N5

Vice chancellor for research, Shiraz University of Medical Sciencesschizophrenia. Schizophrenia

Start: 2011-03-28Target: 56Updated: 2018-02-22

Phase 3

Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in the Treatment of Chronic Hepatitis B

Not yet recruitingNCT07282249

Grand Theravac Life Sciences (Nanjing) Co., Ltd.Chronic hepatitisB

Start: 2025-12-31End: 2027-12-31Target: 630Updated: 2025-12-15

Stratification and Treatment in Early Psychosis Study -ASSIST

Not yet recruitingNCT07326124

University of OxfordPsychosis, Treatment Resistant Psychosis

Start: 2026-06-30End: 2029-09-30Target: 250Updated: 2026-01-08

Phase 4

Comparison of Dexmedetomidine and Meperidine for the Prevention of Shivering Following Coronary Artery Bypass Graft

Qianfoshan HospitalCoronary Artery Disease, Postoperative Shivering

Start: 2021-07-15End: 2022-08-31Target: 180Updated: 2022-01-10

Related Papers

Comparison of dexmedetomidine and meperidine for the prevention of shivering following coronary artery bypass graft: study protocol of a randomised controlled trial

BMJ Open2022-02-015 citations